Impact of Noradrenaline Administration Dosage on the Occurrence of Peripheral Intravenous Catheter–Related Venous Phlebitis in Critically Ill Patients Using a Time‐Dependent Multilevel Cox Regression Model
Emergency Medicine International · 2025-01 · 2025 (1)
DOI: 10.1155/emmi/4457109 ↗Kurz gefasst
Fachartikel in der Zeitschrift Emergency Medicine International, online erschienen am 07.05.2025. Verfasst von Hideto Yasuda und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Research Education and Training Unit, Keio University Hospital Clinical and Translational Research Center (CTR), Shinanomachi …. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Purpose
Peripheral intravenous catheter (PIVC)–administered noradrenaline offers faster treatment for septic shock but risks complications like phlebitis. We aimed to investigate the relationship between the total noradrenaline dose administered via PIVCs and the development of phlebitis by considering the influence of noradrenaline as a time‐dependent covariate.
Methods
A post hoc analysis was conducted on prospective multicenter cohort data from 23 intensive care units in Japan. The total noradrenaline dose was included as a time‐dependent variable in a multilevel Cox regression model, and smoothing splines assessed nonlinear relationships. The primary endpoint was phlebitis. Directed acyclic graphs were used to define confounding factors for the analysis.
Results
The analysis included 3410 PIVCs from 1351 patients, with noradrenaline administered to 70 patients (5.2%) with 91 PIVCs (2.6%). The median dwell time and interquartile range of PIVCs was 46.2 h (21.3–82.9). No significant association was observed between the total noradrenaline dose and the occurrence of phlebitis through analysis using the multilevel Cox regression model with time‐dependent covariate, which assumed the linear relationship between phlebitis occurrence and the total noradrenaline dose (hazard ratio 1.06, 95% confidence interval [CI] 0.93–1.20). Spline curve analysis suggested a nonlinear relationship between the total noradrenaline dose and phlebitis, and the risk of phlebitis increased when the total administered dose of noradrenaline exceeded 6 mg as the lower limit of the 95% CI exceeded the significant threshold of 1.0. Sensitivity analyses, including additional potential risk factors, showed consistent results compared with those of the primary analysis.
Conclusions
Administering noradrenaline within a total dose not exceeding 6 mg reduces the risk of phlebitis, potentially allowing safer administration through PIVCs. Trial Registration: UMIN Clinical Trials Registry (UMIN‐CTR): UMIN000028019
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Research Education and Training Unit, Keio University Hospital Clinical and Translational Research Center (CTR), Shinanomachi 35, Shinjuku-ku, Tokyo 160-8582, Japan.
- Department of Emergency and Critical Care Medicine, Jichi Medical University Saitama Medical Center, 1-847, Amanuma-cho, Omiya-ku, Saitama-shi, Saitama 330-8503, Japan.
- School of Nursing, Midwifery and Social Work, UQ Centre for Clinical Research, The University of Queensland, Building 71/918, Royal Brisbane & Women's Hospital Campus, Herston 4029, Queensland, Australia.
- School of Nursing and Midwifery, Alliance for Vascular Access Teaching and Research, Griffith University, Nathan 4111, Queensland, Australia.
- Herston Infectious Diseases Institute, Nursing and Midwifery Research Centre, Royal Brisbane and Women's Hospital, Metro North Health, Herston, Queensland, Australia.
- Department of Intensive Care Medicine, Kameda Medical Center, 929 Higashi-cho, Chiba, Kamogawa 296-8602, Japan.
ORCID-Profile: Hideto Yasuda, Claire M Rickard, Jessica A Schults, Nicole Marsh, Masahiro Kashiura, Yuki Kishihara, Yutaro Shinzato, Shunsuke Amagasa, Takashi Moriya, Yuki Kotani, Natsuki Kondo, Kosuke Sekine, Nobuaki Shime, Keita Morikane, Takayuki Abe
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Yasuda, H., Rickard, C. M., Schults, J. A., Marsh, N., Kashiura, M., Kishihara, Y., Shinzato, Y., Amagasa, S., Moriya, T., Kotani, Y., Kondo, N., Sekine, K., Shime, N., Morikane, K., Abe, T., & AMOR-VENUS Study Group (2025). Impact of Noradrenaline Administration Dosage on the Occurrence of Peripheral Intravenous Catheter–Related Venous Phlebitis in Critically Ill Patients Using a Time‐Dependent Multilevel Cox Regression Model. Emergency Medicine International, 2025(1). https://doi.org/10.1155/emmi/4457109
Vancouver
Yasuda H, Rickard CM, Schults JA, Marsh N, Kashiura M, Kishihara Y, et al. Impact of Noradrenaline Administration Dosage on the Occurrence of Peripheral Intravenous Catheter–Related Venous Phlebitis in Critically Ill Patients Using a Time‐Dependent Multilevel Cox Regression Model. Emergency Medicine International. 2025;2025(1). doi:10.1155/emmi/4457109
BibTeX
@article{Yasuda2025,
author = {Yasuda, Hideto and Rickard, Claire M and Schults, Jessica A and Marsh, Nicole and Kashiura, Masahiro and Kishihara, Yuki and Shinzato, Yutaro and Amagasa, Shunsuke and Moriya, Takashi and Kotani, Yuki and Kondo, Natsuki and Sekine, Kosuke and Shime, Nobuaki and Morikane, Keita and Abe, Takayuki and AMOR-VENUS Study Group, AMOR-VENUS Study Group},
title = {Impact of Noradrenaline Administration Dosage on the Occurrence of Peripheral Intravenous Catheter–Related Venous Phlebitis in Critically Ill Patients Using a Time‐Dependent Multilevel Cox Regression Model},
journal = {Emergency Medicine International},
year = {2025},
volume = {2025},
number = {1},
doi = {10.1155/emmi/4457109}
}
EUVIMED